#Pradefovir Treatment in Patients with Chronic Hepatitis #B: Week 24 Results from a Multicenter, Double-blind, Randomized, Noninferiority, Phase 2 Trial
https://2medical.news/2021/09/13/pradefovir-treatment-in-patients-with-chronic-hepatitis-b-week-24-results-from-a-multicenter-double-blind-randomized-noninferiority-phase-2-trial/
https://2medical.news/2021/09/13/pradefovir-treatment-in-patients-with-chronic-hepatitis-b-week-24-results-from-a-multicenter-double-blind-randomized-noninferiority-phase-2-trial/
2Medical.News
#Pradefovir Treatment in Patients with Chronic Hepatitis #B: Week 24 Results from a Multicenter, Double-blind, Randomized, Noninferiority…
Pradefovir is a liver-targeted prodrug of adefovir, a nucleotide analog with antiviral activity against hepatitis B virus (HBV) DNA polymerase. This phase 2 study compared the efficacy and safety o…